{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:27:09Z","timestamp":1791268029265,"version":"4.1.0"},"reference-count":86,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2012,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Screening of a transposon insertion mutant library of\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Pseudomonas aeruginosa<\/jats:named-content>\n            for increased susceptibility to paromomycin identified a number of genes whose disruption enhanced susceptibility of this organism to multiple aminoglycosides, including tobramycin, amikacin, and gentamicin. These included genes associated with lipid biosynthesis or metabolism (\n            <jats:italic>lptA<\/jats:italic>\n            ,\n            <jats:italic>faoA<\/jats:italic>\n            ), phosphate uptake (\n            <jats:italic>pstB<\/jats:italic>\n            ), and two-component regulators (\n            <jats:italic>amgRS<\/jats:italic>\n            , PA2797-PA2798) and a gene of unknown function (PA0392). Deletion mutants lacking these showed enhanced panaminoglycoside susceptibility that was reversed by the cloned genes, confirming their contribution to intrinsic panaminoglycoside resistance. None of these mutants showed increased aminoglycoside permeation of the cell envelope, indicating that increased susceptibility was not related to enhanced aminoglycoside uptake owing to a reduced envelope barrier function. Several mutants (\n            <jats:italic>pstB<\/jats:italic>\n            ,\n            <jats:italic>faoA<\/jats:italic>\n            , PA0392,\n            <jats:italic>amgR<\/jats:italic>\n            ) did, however, show increased cytoplasmic membrane depolarization relative to wild type following gentamicin exposure, consistent with the membranes of these mutants being more prone to perturbation, likely by gentamicin-generated mistranslated polypeptides. Mutants lacking any two of these resistance genes in various combinations invariably showed increased aminoglycoside susceptibility relative to single-deletion mutants, confirming their independent contribution to resistance and highlighting the complexity of the intrinsic aminoglycoside resistome in\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">P. aeruginosa<\/jats:named-content>\n            . Deletion of these genes also compromised the high-level panaminoglycoside resistance of clinical isolates, emphasizing their important contribution to acquired resistance.\n          <\/jats:p>","DOI":"10.1128\/aac.01446-12","type":"journal-article","created":{"date-parts":[[2012,8,21]],"date-time":"2012-08-21T04:22:25Z","timestamp":1345522945000},"page":"5591-5602","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":64,"title":["Determinants of Intrinsic Aminoglycoside Resistance in Pseudomonas aeruginosa"],"prefix":"10.1128","volume":"56","author":[{"given":"Thomas","family":"Krahn","sequence":"first","affiliation":[{"name":"Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie","family":"Gilmour","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Tilak","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Fraud","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Kerr","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin Ho-Fung","family":"Lau","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Poole","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","volume-title":"Short protocols in molecular biology","author":"Ausubel FM","year":"1992","unstructured":"AusubelFM. 1992. Short protocols in molecular biology, 2nd ed. John Wiley & Sons, Inc., New York, NY.","edition":"2"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.28185-0"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2760(94)90113-9"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.7164\/antibiotics.29.743","article-title":"Gentamicin resistance in clinical-isolates of Pseudomonas aeruginosa associated with diminished gentamicin accumulation and no detectable enzymatic modification","volume":"29","author":"Bryan LE","year":"1976","unstructured":"BryanLE HaraphongseR Van den ElzenHM. 1976. Gentamicin resistance in clinical-isolates of Pseudomonas aeruginosa associated with diminished gentamicin accumulation and no detectable enzymatic modification. J. Antibiot. (Tokyo) 29:743\u2013753.","journal-title":"J. Antibiot. (Tokyo)"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.17.1.71"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.2.250"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.9.6.928"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.12.2.163"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl328"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1469-0691.2005.01217.x","article-title":"Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients","volume":"11","author":"Canton R","year":"2005","unstructured":"CantonR. 2005. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Clin. Microbiol. Infect. 11:690\u2013703.","journal-title":"Clin. Microbiol. Infect."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mimet.2005.06.001"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)44891-5"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280009"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.149.3688.1096"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/mr.51.3.341-350.1987"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.16.6164"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.6.1761-1770.2001"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1128\/jb.172.11.6568-6572.1990","article-title":"Mini-Tn5 transposon derivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in Gram-negative eubacteria","volume":"172","author":"de Lorenzo V","year":"1990","unstructured":"de LorenzoV HerreroM JakubzikU TimmisKN. 1990. Mini-Tn5 transposon derivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in Gram-negative eubacteria. J. Bacteriol. 172:6567\u20136572.","journal-title":"J. Bacteriol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1086\/518605"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00429636","article-title":"Induction of polymyxin resistance in Pseudomonas fluorescens by phosphate limitation","volume":"114","author":"Dorrer E","year":"1977","unstructured":"DorrerE TeuberM. 1977. Induction of polymyxin resistance in Pseudomonas fluorescens by phosphate limitation. Arch. Microbiol. 114:87\u201389.","journal-title":"Arch. Microbiol."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00035-09"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn174"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.01480-10"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2009.06.018"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00704-06"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1098\/rstb.1996.0052","article-title":"Control of the cell-specificity of sigma F activity in Bacillus subtilis","volume":"351","author":"Errington J","year":"1996","unstructured":"ErringtonJ. 1996. Control of the cell-specificity of sigma F activity in Bacillus subtilis. Philos. Trans. R. Soc. Lond. B Biol. Sci. 351:537\u2013542.","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldn050"},{"issue":"1","key":"e_1_3_2_29_2","first-page":"E050127.2","article-title":"Emergence and dissemination of a new mechanism of resistance to aminoglycosides in Gram-negative bacteria: 16S rRNA methylation","volume":"10","author":"Galimand M","year":"2005","unstructured":"GalimandM LambertT CourvalinP. 2005. Emergence and dissemination of a new mechanism of resistance to aminoglycosides in Gram-negative bacteria: 16S rRNA methylation. Euro Surveill. 10(1):E050127.2.","journal-title":"Euro Surveill."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00315-10"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.4187\/aarc0537"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.7.1309"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/jac\/8.6.429","article-title":"Aminoglycoside uptake and mode of action with specific reference to streptomycin and gentamicin. II. Effects of aminoglycosides on cells","volume":"8","author":"Hancock REW","year":"1981","unstructured":"HancockREW. 1981. Aminoglycoside uptake and mode of action with specific reference to streptomycin and gentamicin. II. Effects of aminoglycosides on cells. J. Antimicrob. Chemother. 8:429\u2013445.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01975036"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.micro.61.080706.093445"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00148-07"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1086\/591861"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.05133-11"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(98)00130-9"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01212-07"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2008.02097.x"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.micro.59.030804.121316"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1271\/bbb.90558"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-005-0279-0"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.3.1101-1111.2003"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.049445-0"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.4.715"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.2008\/018135-0"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(88)90117-5"},{"key":"e_1_3_2_50_2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/jac\/dkn244","article-title":"Occurrence and mechanisms of amikacin resistance and its association with \u03b2-lactamases in Pseudomonas aeruginosa: a Korean nationwide study","volume":"62","author":"Kim JY","year":"2008","unstructured":"KimJY. 2008. Occurrence and mechanisms of amikacin resistance and its association with \u03b2-lactamases in Pseudomonas aeruginosa: a Korean nationwide study. J. Antimicrob. Chemother. 62:479\u2013483.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.06.049"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.09.038"},{"key":"e_1_3_2_53_2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7164\/antibiotics.29.169","article-title":"Mechanisms of streptomycin (SM)-resistance of highly SM-resistant Pseudomonas aeruginosa strains","volume":"29","author":"Kono M","year":"1976","unstructured":"KonoM O'HaraK. 1976. Mechanisms of streptomycin (SM)-resistance of highly SM-resistant Pseudomonas aeruginosa strains. J. Antibiot. (Tokyo) 29:169\u2013175.","journal-title":"J. Antibiot. (Tokyo)"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-009-9549-x"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0903619106"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.4.546"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-146-10-2543"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05958-11"},{"key":"e_1_3_2_59_2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijantimicag.2004.11.009","article-title":"Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre","volume":"25","author":"Manno G","year":"2005","unstructured":"MannoG. 2005. Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre. Int. J. Antimicrob. Agents 25:193\u2013197.","journal-title":"Int. J. Antimicrob. Agents"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.9.1847"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2003.03673.x"},{"key":"e_1_3_2_62_2","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1378\/chest.06-2888","article-title":"Incidence and risk factors for multiple antibiotic-resistant Pseudomonas aeruginosa in cystic fibrosis","volume":"132","author":"Merlo CA","year":"2007","unstructured":"MerloCA. 2007. Incidence and risk factors for multiple antibiotic-resistant Pseudomonas aeruginosa in cystic fibrosis. Chest 132:562\u2013568.","journal-title":"Chest"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.170.6.2575-2583.1988"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.188.5.1847-1855.2006"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.20873"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000213"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02172980"},{"key":"e_1_3_2_68_2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/infdis\/158.5.1003","article-title":"Mechanisms of aminoglycoside resistance in variants of Pseudomonas aeruginosa isolated during treatment of experimental endocarditis in rabbits","volume":"158","author":"Parr TR","year":"1988","unstructured":"ParrTRJr BayerAS. 1988. Mechanisms of aminoglycoside resistance in variants of Pseudomonas aeruginosa isolated during treatment of experimental endocarditis in rabbits. J. Infect. Dis. 158:1003\u20131010.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.2.479-487.2005"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.micro.56.012302.161038"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2009.06.010"},{"key":"e_1_3_2_72_2","volume-title":"Molecular cloning: a laboratory manual","author":"Sambrook J","year":"2001","unstructured":"SambrookJ RussellDW. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.","edition":"3"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00507-08"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.12.2877"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-146-8-2019"},{"key":"e_1_3_2_76_2","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1099\/00221287-147-8-2367","article-title":"gmhX, a novel gene required for the incorporation of l-glycero-d-manno-heptose into lipooligosaccharide in Neisseria meningitidis","volume":"147","author":"Shih GC","year":"2001","unstructured":"ShihGC KahlerCM CarlsonRW RahmanMM StephensDS. 2001. gmhX, a novel gene required for the incorporation of l-glycero-d-manno-heptose into lipooligosaccharide in Neisseria meningitidis. Microbiology 147:2367\u20132377.","journal-title":"Microbiology"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1183-784"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.10.3202-3207.2003"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.187.4.1246-1253.2005"},{"key":"e_1_3_2_80_2","first-page":"369","article-title":"Aminoglycoside resistance due to alterations of transport mechanisms","volume":"1","author":"Stefani S","year":"1989","unstructured":"StefaniS RussoG. 1989. Aminoglycoside resistance due to alterations of transport mechanisms. J. Chemother. 1:369\u2013370.","journal-title":"J. Chemother."},{"key":"e_1_3_2_81_2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2958.1995.mmi_18030401.x","article-title":"Membrane glycerophospholipid biosynthesis in Neisseria meningitidis and Neisseria gonorrhoeae: identification, characterization, and mutagenesis of a lysophosphatidic acid acyltransferase","volume":"18","author":"Swartley JS","year":"1995","unstructured":"SwartleyJS BalthazarJT ColemanJ ShaferWM StephensDS. 1995. Membrane glycerophospholipid biosynthesis in Neisseria meningitidis and Neisseria gonorrhoeae: identification, characterization, and mutagenesis of a lysophosphatidic acid acyltransferase. Mol. Microbiol. 18:401\u2013412.","journal-title":"Mol. Microbiol."},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1128\/mr.51.4.439-457.1987"},{"key":"e_1_3_2_83_2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1179\/joc.2008.20.2.166","article-title":"Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis","volume":"20","author":"Taccetti G","year":"2008","unstructured":"TaccettiG CampanaS NeriAS BoniV FestiniF. 2008. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis. J. Chemother. 20:166\u2013169.","journal-title":"J. Chemother."},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2011.04.002"},{"key":"e_1_3_2_85_2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3201\/eid1304.060501","article-title":"16S rRNA methylase-producing, Gram-negative pathogens, Japan","volume":"13","author":"Yamane K","year":"2007","unstructured":"YamaneK. 2007. 16S rRNA methylase-producing, Gram-negative pathogens, Japan. Emerg. Infect. Dis. 13:642\u2013646.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(85)90120-9"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00469-10"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01446-12","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01446-12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:58:01Z","timestamp":1645480681000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01446-12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":86,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["10.1128\/AAC.01446-12"],"URL":"https:\/\/doi.org\/10.1128\/aac.01446-12","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"2012-07-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-08-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-10-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}